Company intelligence / Profile preview

Santo Holding

Shymkent, Kazakhstan

Ownership: Private
Employees: ~4000
Development stage: Other

Overview

SANTO is one of the largest pharmaceutical manufacturers in Central Asia, commercializing over 240 drugs including antibiotics, cardiovascular, anesthesia, pain management, and diabetes medicines. The company maintains European manufacturing standards and has recently expanded production capacity, R&D, and export capabilities to neighboring countries.

Therapeutic areas: OtherEndocrinologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeBiologicVaccine
Industry: Biotech

Beyond the preview

Go deeper on Santo Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Santo Holding.

Explore the full profile